Monsanto to drop all requests for new GM crops in EU

The following is an edited excerpt.

US seed producer Monsanto has said it would withdraw all new requests to grow genetically modified crops in the EU. The move reflects its frustration over ongoing resistance to GM crops among populations in Europe.

All approval requests for new types of genetically modified (GM) crops filed with the European Union would be stopped within the next few months, Monsanto President and Managing Director for Europe Jose Manuel Madero told British news agency Reuters on Wednesday.

The withdrawal would affect requests for growing genetically modified maize, one soybean and one sugar beet, Madero was quoted as saying.

The move was prompted by a lack of commercial prospects for cultivating GMOs (genetically modified organisms) in the 28-nation bloc, and came as the US-based company was re-focusing on its conventional seeds business in Europe, Madero added.

Read the full story here: Monsanto to drop all requests for new GM crops in EU

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine “hero” vs. an anti-vax “villain”: ‘Bad Vaxx’ video stirs MAHA backlash
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpoint— 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.